CY1105321T1 - Μη πεπτιδικοι ανταγωνιστες υποδοχεα ccr1 σε συνδυασμο με κυκλοσπορινη α για τη θepαπεια της απορριψης καρδιακου μοσχευματος - Google Patents

Μη πεπτιδικοι ανταγωνιστες υποδοχεα ccr1 σε συνδυασμο με κυκλοσπορινη α για τη θepαπεια της απορριψης καρδιακου μοσχευματος

Info

Publication number
CY1105321T1
CY1105321T1 CY20061101266T CY061101266T CY1105321T1 CY 1105321 T1 CY1105321 T1 CY 1105321T1 CY 20061101266 T CY20061101266 T CY 20061101266T CY 061101266 T CY061101266 T CY 061101266T CY 1105321 T1 CY1105321 T1 CY 1105321T1
Authority
CY
Cyprus
Prior art keywords
cyclosporin
treatment
rejection
granplant
cardiac
Prior art date
Application number
CY20061101266T
Other languages
English (en)
Inventor
Richard Horuk
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of CY1105321T1 publication Critical patent/CY1105321T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αυτή κατευθύνεται προς φαρμακευτικές συνθέσεις χρήσιμες στη θεραπεία απόρριψης μοσχεύματος καρδιάς σε θηλαστικά περιλαμβάνουσα ένα φαρμακευτικά αποδεκτό έκδοχο, μια θεραπευτικά αποδεκτή ποσότητα από ένα μη πεπτιδικό ανταγωνιστή υποδοχέα CCR1 και μια υπο-νεφροτοξική ποσότητα κυκλοσπορίνης Α.
CY20061101266T 2000-07-31 2006-09-05 Μη πεπτιδικοι ανταγωνιστες υποδοχεα ccr1 σε συνδυασμο με κυκλοσπορινη α για τη θepαπεια της απορριψης καρδιακου μοσχευματος CY1105321T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22205300P 2000-07-31 2000-07-31
US23128200P 2000-09-08 2000-09-08
US09/915,411 US6740636B2 (en) 2000-07-31 2001-07-25 Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
PCT/US2001/023862 WO2002009762A2 (en) 2000-07-31 2001-07-31 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection

Publications (1)

Publication Number Publication Date
CY1105321T1 true CY1105321T1 (el) 2010-03-03

Family

ID=27397025

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101266T CY1105321T1 (el) 2000-07-31 2006-09-05 Μη πεπτιδικοι ανταγωνιστες υποδοχεα ccr1 σε συνδυασμο με κυκλοσπορινη α για τη θepαπεια της απορριψης καρδιακου μοσχευματος

Country Status (28)

Country Link
US (1) US6740636B2 (el)
EP (1) EP1305047B1 (el)
JP (1) JP2004530630A (el)
KR (1) KR20030048000A (el)
CN (1) CN1655818A (el)
AT (1) ATE330634T1 (el)
AU (2) AU7807301A (el)
BG (1) BG107502A (el)
BR (1) BR0113140A (el)
CA (1) CA2417636A1 (el)
CY (1) CY1105321T1 (el)
DE (1) DE60120986T2 (el)
DK (1) DK1305047T3 (el)
EE (1) EE200300047A (el)
ES (1) ES2261447T3 (el)
HR (1) HRP20030121A2 (el)
HU (1) HUP0300686A3 (el)
IL (1) IL153933A0 (el)
LV (1) LV13033B (el)
MX (1) MXPA03000836A (el)
NO (1) NO20030475L (el)
NZ (1) NZ523688A (el)
PL (1) PL364521A1 (el)
PT (1) PT1305047E (el)
SI (1) SI21123A (el)
SK (1) SK1222003A3 (el)
WO (1) WO2002009762A2 (el)
YU (1) YU6703A (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2006108865A (ru) * 2003-08-22 2007-09-27 Шеринг Акциенгезельшафт (De) Производные пиперазина, которые ингибируют хемокины, и их применение для лечения миокардита
US7917195B2 (en) 2004-03-05 2011-03-29 Lifesciences Solutions LLC Systems, methods and computer program products for heart monitoring
US10499828B2 (en) * 2004-03-05 2019-12-10 Lifescience Solutions, Llc System and method for heart monitoring
US8103065B2 (en) * 2006-01-05 2012-01-24 Lifescience Solutions Llc Assessment of medical conditions
US20110009758A1 (en) * 2009-07-10 2011-01-13 Lifescience Solutions Llc System and method for heart monitoring

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
CN1248968A (zh) 1997-02-26 2000-03-29 辉瑞大药厂 杂芳基－己酸酰胺衍生物、其制备方法及其作为MIP－1α与其CCRI受体结合的选择性抑制剂的用途
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6433165B1 (en) 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
BR9910144A (pt) 1998-01-21 2002-04-02 Millennium Pharm Inc Antagonistas de receptores de quimiocinas e seu uso
KR100385529B1 (ko) 1998-02-05 2003-05-27 화이자 프로덕츠 인코포레이티드 신규 디하이드록시헥산산 유도체
EP1000626A1 (en) 1998-09-18 2000-05-17 Applied Research Systems ARS Holding N.V. Chemokine receptor antagonist and cyclosporin in combined therapy
AU2862300A (en) 1999-01-29 2000-08-18 Millennium Pharmaceuticals, Inc. Methods for preventing graft rejection and ischemia-reperfusion injury

Also Published As

Publication number Publication date
WO2002009762A2 (en) 2002-02-07
WO2002009762A3 (en) 2003-01-09
SI21123A (sl) 2003-08-31
DE60120986D1 (de) 2006-08-03
ATE330634T1 (de) 2006-07-15
MXPA03000836A (es) 2003-06-06
BR0113140A (pt) 2003-06-24
CN1655818A (zh) 2005-08-17
CA2417636A1 (en) 2002-02-07
AU2001278073B2 (en) 2005-06-30
SK1222003A3 (en) 2003-09-11
NO20030475D0 (no) 2003-01-30
DE60120986T2 (de) 2006-11-23
HRP20030121A2 (en) 2005-02-28
JP2004530630A (ja) 2004-10-07
DK1305047T3 (da) 2006-10-23
EE200300047A (et) 2004-10-15
US6740636B2 (en) 2004-05-25
IL153933A0 (en) 2003-07-31
EP1305047A2 (en) 2003-05-02
LV13033B (en) 2004-02-20
US20020039997A1 (en) 2002-04-04
EP1305047B1 (en) 2006-06-21
NZ523688A (en) 2005-04-29
HUP0300686A2 (hu) 2003-08-28
PT1305047E (pt) 2006-11-30
HUP0300686A3 (en) 2005-03-29
ES2261447T3 (es) 2006-11-16
PL364521A1 (en) 2004-12-13
BG107502A (en) 2003-07-31
AU7807301A (en) 2002-02-13
NO20030475L (no) 2003-03-28
KR20030048000A (ko) 2003-06-18
YU6703A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
DE60318891D1 (de) Cyclopropylverbindungen als ccr5 antagonisten
DE69818831D1 (de) Indolderivate als mcp-1 rezeptor antagonisten
TR200100172T2 (tr) Oral katı doz formunda eprosartan içeren biyolojik bakımdan kuvvetlendirilmiş formülasyonlar
TW200635897A (en) Piperidine derivatives and their use as anti-inflammatory agents
DE60323133D1 (de) Cyclohexylverbindungen als ccr5-antagonisten
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
CY1105257T1 (el) Χρηση των ανταγωνιστων των υποδοχεων της αγγειοτενσινης ii στην θepαπεια του οξεος εμφραγματος του μυοκαρδιου
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
CY1105321T1 (el) Μη πεπτιδικοι ανταγωνιστες υποδοχεα ccr1 σε συνδυασμο με κυκλοσπορινη α για τη θepαπεια της απορριψης καρδιακου μοσχευματος
EA200600480A1 (ru) Имидазопиридинзамещённые тропановые производные, обладающие активностью антагониста ccr5 рецептора, для лечения вируса иммунодефицита человека (вич) и воспаления
ATE410426T1 (de) Heterocyclische verbindungen alsccr5-antagonisten
CY1105302T1 (el) Μη-πεπτιδιο ανταγωνιστες υποδοχεα ccr1 για την θepαπεια προϊουσης νεφρικης ινωσης
IL154358A0 (en) Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
CY1106540T1 (el) Ετεροκυλικα υποκατεστημενες στη θεση 3 πιπεριδινο-2,6-διονες
LT2003015A (en) Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection
WO2001079193A3 (en) Substituted hydrazinyl heteroaromatic inhibitors of thrombin
AR018825A1 (es) Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas
ITFI20030238A1 (it) Peptidi ciclici antagonisti dell'urotensina-ii
TH101946A (th) การรักษาอาการกลั้นปัสสาวะไม่อยู่